Non‐Inferiority Trials to Evaluate Drug Effects in Rheumatoid Arthritis

Review of previous placebo controlled studies informed a meta-analysis to estimate the effects of TNF inhibitors on RA symptoms, and to determine a non-inferiority margin between treatments to be used for new studies. Authors suggest a range from 0.10 and 0.12.

Source:

Arthritis & Rheumatology